Pamela Foulds

Pamela Foulds is a medical doctor who has worked in the pharmaceutical and biotech industry for over 20 years. Pamela is currently the Chief Medical Officer at Freeline Therapeutics.

Pamela Foulds graduated from Stanford University Medical Center with their MD in 1996. Pamela then completed a residency in Neurology at Georgetown University Medical Center from 1995 to 1996. After their residency, they worked as a Clinical Research Physician at UCB from 1999 to 2001. In 2001, they joined Integrated Communications as their VP, Medical Director and worked there until 2003 when they moved to Genzyme. At Genzyme, Pamela Foulds was the Medical Director for Global Medical Programs from 2003 to 2006. In 2006, they left Genzyme to join Biogen Idec as their Senior Medical Director for Global Medical Affairs, a position they held until 2014.

In 2017, Pamela Foulds left Biogen Idec to become the CMO of Auregen BioTherapeutics where they worked until 2020. Pamela then rejoined Freeline Therapeutics as their Chief Medical Officer.

Pamela Foulds attended Georgetown University for their undergraduate and medical degrees. Pamela first obtained a Bachelor of Science in Pre-Medicine/Pre-Medical Studies and then went on to earn their Doctor of Medicine. Pamela is currently practicing medicine as a career.

Their manager is Michael Parini, CEO & Director. They work with Eric Fink - Chief Human Resources Officer, Mark Baldry - Chief Commercial Officer, and Benjamin Warriner - VP of Finance.